Sex differences in survival of cutaneous melanoma are age dependent: An analysis of 7338 patients

Melanoma Research

Volumn 21, Issue 3, 2011, Pages 244-252

  Mervic, Liljana ^a,b   Leiter, Ulrike ^b   Meier, Friedegund ^b   Eigentler, Thomas ^b   Forschner, Andrea ^b   Metzler, Gisela ^b   Bartenjev, Igor ^c   Büttner, Petra ^d   Garbe, Claus ^b,d  

^a University of Tudie bingen   (Germany)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

^d JAMES COOK UNIVERSITY   (Australia)

Author keywords

age dependency; clinical presentation; cutaneous melanoma; melanoma related survival; sex difference

Indexed keywords

ADULT; AGE; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; DISEASE SPECIFIC SURVIVAL; FEMALE; GERMANY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE FREE SURVIVAL; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; FEMALE; GERMANY; HUMANS; MALE; MELANOMA; MIDDLE AGED; SEX FACTORS; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 79955635289     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e32834577c8     Document Type: Article

References (39)

1. Kolmel KF, Kulle B, Lippold A, Seebacher C. Survival probabilities and hazard functions of malignant melanoma in Germany 1972-1996, an analysis of 10 433 patients: evolution of gender differences and malignancy. Eur J Cancer 2002; 38:1388-1394. (Pubitemid 34686851)
2. Lasithiotakis K, Leiter U, Meier F, Eigentler T, Metzler G, Moehrle M, et al. Age and gender are significant independent predictors of survival in primary cutaneous melanoma. Cancer 2008; 112:1795-1804. (Pubitemid 351536840)
3. Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Goydos JS, Beitsch PD, et al. Gender-related differences in outcome for melanoma patients. Ann Surg 2006; 243:693-698. (Pubitemid 44305591)
4. Aase A, Bentham G. Gender, geography and socio-economic status in the diffusion of malignant melanoma risk. Soc Sci Med 1996; 42:1621-1637.
5. Lasithiotakis KG, Leiter U, Eigentler T, Breuninger H, Metzler G, Meier F, et al. Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976-2001: which factors contributed? Cancer 2007; 109:1174-1182. (Pubitemid 46435398)
6. Quatresooz P, Uhoda I, Fumal I, Pierard-Franchimont C, Pierard GE. Revisiting the gender-linked melanoma burden. Dermatology 2004; 209:197-201. (Pubitemid 39370327)
7. Mackie RM, Hauschild A, Eggermont AM. Epidemiology of invasive cutaneous melanoma. Ann Oncol 2009; 20 (Suppl 6):vi1-vi7.
8. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19:3622-3634. (Pubitemid 32786275)
9. Lasithiotakis KG, Leiter U, Gorkievicz R, Eigentler T, Breuninger H, Metzler G, et al. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976-2003. Cancer 2006; 107:1331-1339. (Pubitemid 44452783)
10. Garbe C, Mcleod GR, Buettner PG. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer 2000; 89:1269-1278.
11. Brandberg Y, Bolund C, Michelson H, Mansson-Brahme E, Ringborg U, Sjoden PO. Perceived susceptibility to and knowledge of malignant melanoma: screening participants versus the general population. Prev Med 1996; 25:170-177. (Pubitemid 26144350)
12. Olak J, Colson Y. Gender differences in lung cancer: have we really come a long way, baby? J Thorac Cardiovasc Surg 2004; 128:346-351. (Pubitemid 39194686)
13. Wisnivesky JP, Halm EA. Sex differences in lung cancer survival: do tumors behave differently in elderly women? J Clin Oncol 2007; 25:1705-1712. (Pubitemid 46797951)
14. Lincourt AE, Sing RF, Kercher KW, Stewart A, Demeter BL, Hope WW, et al. Association of demographic and treatment variables in long-term colon cancer survival. Surg Innov 2008; 15:17-25. (Pubitemid 351546662)
15. Leiter U, Meier F, Schittek B, Garbe C. The natural course of cutaneous melanoma. J Surg Oncol 2004; 86:172-178. (Pubitemid 38880283)
16. Autier P, Boniol M, Severi G, Pedeux R, Grivegnee AR, Dore JF. Sex differences in numbers of nevi on body sites of young European children: implications for the etiology of cutaneous melanoma. Cancer Epidemiol Biomarkers Prev 2004; 13:2003-2005. (Pubitemid 40054292)
17. Clark LN, Shin DB, Troxel AB, Khan S, Sober AJ, Ming ME. Association between the anatomic distribution of melanoma and sex. J Am Acad Dermatol 2007; 56:768-773. (Pubitemid 46561015)
18. Bernengo MG, Reali UM, Doveil GC, Cappello N, Lisa F, Moretti S. BANS: a discussion of the problem. Melanoma Res 1992; 2:157-162.
19. Garbe C, Buttner P, Bertz J, Burg G, d'Hoedt B, Drepper H, et al. Primary cutaneous melanoma: prognostic classification of anatomic location. Cancer 1995; 75:2492-2498.
20. Holman CD, Armstrong BK, Heenan PJ. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors. Br J Cancer 1984; 50:673-680. (Pubitemid 15211638)
21. Miller JG, Gee J, Price A, Garbe C, Wagner M, Mac NS. Investigation of oestrogen receptors, sex steroids and soluble adhesion molecules in the progression of malignant melanoma. Melanoma Res 1997; 7:197-208. (Pubitemid 27283500)
22. Richardson B, Price A, Wagner M, Williams V, Lorigan P, Browne S, et al. Investigation of female survival benefit in metastatic melanoma. Br J Cancer 1999; 80:2025-2033. (Pubitemid 29391291)
23. Lens MB, Reiman T, Husain AF. Use of tamoxifen in the treatment of malignant melanoma. Cancer 2003; 98:1355-1361.
24. Lens M, Rosdahl I, Newton-Bishop J. Cutaneous melanoma during pregnancy: is the controversy over? J Clin Oncol 2009; 27:11-12.
25. Driscoll MS, Grant-Kels JM. Melanoma and pregnancy. G Ital Dermatol Venereol 2008; 143:251-257.
26. Paharkova-Vatchkova V, Maldonado R, Kovats S. Estrogen preferentially promotes the differentiation of CD11c + CD11b(intermediate) dendritic cells from bone marrow precursors. J Immunol 2004; 172:1426-1436. (Pubitemid 38116784)
27. Miller JG, Mac NS. Gender and cutaneous melanoma. Br J Dermatol 1997; 136:657-665. (Pubitemid 27278070)
28. Miller L, Hunt JS. Sex steroid hormones and macrophage function. Life Sci 1996; 59:1-14. (Pubitemid 26198120)
29. Joosse A, de Vries E, van Eijck CH, Eggermont AM, Nijsten T, Coebergh JW. Reactive oxygen species and melanoma: an explanation for gender differences in survival? Pigment Cell Melanoma Res 2010; 23:352-364.
30. De Vries E, Nijsten TE, Visser O, Bastiaannet E, van Hattem S, Janssen-Heijnen ML, et al. Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site. Ann Oncol 2008; 19:583-589. (Pubitemid 351325683)
31. Micheli A, Ciampichini R, Oberaigner W, Ciccolallo L, de Vries E, Izarzugaza I, et al. The advantage of women in cancer survival: an analysis of EUROCARE-4 data. Eur J Cancer 2009; 45:1017-1027.
32. Kemeny MM, Busch E, Stewart AK, Menck HR. Superior survival of young women with malignant melanoma. Am J Surg 1998; 175:437-444.
33. Cocconi G, Bella M, Calabresi F, Tonato M, Canaletti R, Boni C, et al. Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen. N Engl J Med 1992; 327:516-523.
34. Karjalainen S, Hakulinen T. Survival and prognostic factors of patients with skin melanoma: a regression model analysis based on nationwide cancer registry data. Cancer 1988; 62:2274-2280. (Pubitemid 18261873)
35. Shaw HM, McGovern VJ, Milton GW, Farago GA, McCarthy WH. Malignant melanoma: influence of site of lesion and age of patient in the female superiority in survival. Cancer 1980; 46:2731-2735. (Pubitemid 11210244)
36. Malaguarnera L, Ferlito L, Di Mauro S, Imbesi RM, Scalia G, Malaguarnera M. Immunosenescence and cancer: a review. Arch Gerontol Geriatr 2001; 32:77-93. (Pubitemid 32335564)
37. Nomellini V, Gomez CR, Kovacs EJ. Aging and impairment of innate immunity. Contrib Microbiol 2008; 15:188-205.
38. Hintze J. PASS 2008. Kaysville, Utah: NCSS, LLC; 2008. USA.www.ncss.com.
39. Gutzmer R, Al Ghazal M, Geerlings H, Kapp A. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients. Br J Dermatol 2005; 153:1137-1141. (Pubitemid 41779567)